In Brief
- New smart cancer drug activates only inside cancer cells.
- The drug aims to minimize harm to healthy cells compared to chemotherapy.
- It is designed to ‘switch on’ selectively within cancerous cells.
- Government suggests this drug could replace chemotherapy treatments.
The government announced the development of a new smart cancer drug that is designed to 'switch on' exclusively inside cancer cells. This targeted activation ensures that the drug works precisely where needed, sparing healthy cells from damage typically caused by chemotherapy.
The innovation marks a significant advancement in cancer treatment by potentially reducing the severe side effects associated with conventional chemotherapy. According to officials, this drug’s selective mechanism allows it to operate only within cancerous cells, enhancing treatment efficiency and patient safety.
Authorities noted that this smart drug may eventually replace chemotherapy as the standard treatment approach, offering hope for better outcomes and improved quality of life for cancer patients.
